Laird Norton Wetherby Wealth Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.84M | Sell |
81,536
-1,476
| -2% | -$122K | 0.28% | 49 |
|
|
2025
Q2 | $6.57M | Buy |
+83,012
| New | +$6.6M | 0.29% | 52 |
|
|
2024
Q4 | $12.3M | Sell |
123,158
-440
| -0.4% | -$45.4K | 0.59% | 22 |
|
|
2024
Q3 | $14M | Sell |
123,598
-3,088
| -2% | -$367K | 0.64% | 22 |
|
|
2024
Q2 | $15.7M | Buy |
126,686
+6,883
| +6% | +$887K | 0.74% | 17 |
|
|
2024
Q1 | $15.8M | Sell |
119,803
-4,547
| -4% | -$560K | 0.75% | 17 |
|
|
2023
Q4 | $13.6M | Buy |
124,350
+933
| +0.8% | +$96.8K | 0.71% | 17 |
|
|
2023
Q3 | $12.7M | Sell |
123,417
-730
| -0.6% | -$78.7K | 0.72% | 18 |
|
|
2023
Q2 | $14.3M | Sell |
124,147
-234
| -0.2% | -$26.6K | 0.77% | 14 |
|
|
2023
Q1 | $13.2M | Buy |
124,381
+3,294
| +3% | +$356K | 0.77% | 15 |
|
|
2022
Q4 | $13.4M | Buy |
121,087
+1,924
| +2% | +$197K | 0.86% | 12 |
|
|
2022
Q3 | $10.3M | Buy |
119,163
+2,683
| +2% | +$240K | 0.72% | 13 |
|
|
2022
Q2 | $10.6M | Buy |
116,480
+4,442
| +4% | +$394K | 0.72% | 14 |
|
|
2022
Q1 | $9.19M | Buy |
112,038
+2,856
| +3% | +$225K | 0.53% | 27 |
|
|
2021
Q4 | $8.37M | Sell |
109,182
-51
| -0% | -$4.06K | 0.47% | 32 |
|
|
2021
Q3 | $8.2M | Buy |
109,233
+2,748
| +3% | +$209K | 0.51% | 30 |
|
|
2021
Q2 | $8.28M | Sell |
106,485
-3,485
| -3% | -$259K | 0.51% | 30 |
|
|
2021
Q1 | $8.09M | Sell |
109,970
-10,048
| -8% | -$741K | 0.62% | 27 |
|
|
2020
Q4 | $9.37M | Buy |
120,018
+4,167
| +4% | +$319K | 0.64% | 24 |
|
|
2020
Q3 | $9.17M | Buy |
115,851
+3,777
| +3% | +$296K | 0.82% | 16 |
|
|
2020
Q2 | $8.27M | Buy |
112,074
+9,213
| +9% | +$694K | 0.78% | 18 |
|
|
2020
Q1 | $7.55M | Buy |
102,861
+40,599
| +65% | +$3.19M | 0.85% | 18 |
|
|
2019
Q4 | $5.4M | Sell |
62,262
-41,823
| -40% | -$3.44M | 0.53% | 28 |
|
|
2019
Q3 | $8.36M | Buy |
104,085
+1,231
| +1% | +$98.7K | 0.87% | 18 |
|
|
2019
Q2 | $8.23M | Buy |
102,854
+1,097
| +1% | +$84K | 0.9% | 16 |
|
|
2019
Q1 | $8.08M | Buy |
101,757
+1,492
| +1% | +$112K | 1.01% | 13 |
|
|
2018
Q4 | $7.31M | Buy |
100,265
+2,521
| +3% | +$178K | 1.03% | 13 |
|
|
2018
Q3 | $6.62M | Sell |
97,744
-1,025
| -1% | -$65.3K | 0.82% | 18 |
|
|
2018
Q2 | $5.72M | Buy |
98,769
+1,766
| +2% | +$99.6K | 0.77% | 19 |
|
|
2018
Q1 | $5.04M | Buy |
97,003
+1,398
| +1% | +$75.5K | 0.7% | 21 |
|
|
2017
Q4 | $5.13M | Sell |
95,605
-1,845
| -2% | -$102K | 0.71% | 18 |
|
|
2017
Q3 | $5.95M | Buy |
97,450
+328
| +0.3% | +$19.9K | 0.89% | 16 |
|
|
2017
Q2 | $5.94M | Buy |
97,122
+2,577
| +3% | +$157K | 1.01% | 15 |
|
|
2017
Q1 | $5.73M | Sell |
94,545
-270
| -0.3% | -$16.4K | 1.03% | 14 |
|
|
2016
Q4 | $5.33M | Buy |
94,815
+777
| +0.8% | +$45.5K | 1.04% | 14 |
|
|
2016
Q3 | $5.6M | Buy |
94,038
+507
| +0.5% | +$29.6K | 1.13% | 13 |
|
|
2016
Q2 | $5.14M | Buy |
93,531
+1,335
| +1% | +$71K | 1.14% | 12 |
|
|
2016
Q1 | $4.65M | Buy |
92,196
+2,195
| +2% | +$108K | 1.1% | 14 |
|
|
2015
Q4 | $4.54M | Sell |
90,001
-372
| -0.4% | -$18.8K | 1.09% | 14 |
|
|
2015
Q3 | $4.26M | Buy |
90,373
+1,624
| +2% | +$86.3K | 1.09% | 15 |
|
|
2015
Q2 | $4.82M | Buy |
88,749
+1,895
| +2% | +$106K | 1.16% | 11 |
|
|
2015
Q1 | $4.76M | Buy |
86,854
+313
| +0.4% | +$17.7K | 1.16% | 12 |
|
|
2014
Q4 | $4.69M | Buy |
86,541
+1,113
| +1% | +$62K | 1.18% | 12 |
|
|
2014
Q3 | $4.83M | Buy |
85,428
+295
| +0.3% | +$16.6K | 1.35% | 10 |
|
|
2014
Q2 | $4.7M | Buy |
85,133
+665
| +0.8% | +$36.3K | 1.33% | 10 |
|
|
2014
Q1 | $4.58M | Sell |
84,468
-2,918
| -3% | -$151K | 1.31% | 9 |
|
|
2013
Q4 | $4.17M | Buy |
87,386
+2,392
| +3% | +$109K | 1.19% | 10 |
|
|
2013
Q3 | $3.86M | Buy |
84,994
+2,237
| +3% | +$102K | 1.2% | 12 |
|
|
2013
Q2 | $3.67M | Buy |
+82,757
| New | +$3.7M | 1.28% | 12 |
|
Other funds holding MRK
Laird Norton Wetherby Wealth Management's MRK Position: Q3 2025 in Review
Laird Norton Wetherby Wealth Management reduced its Merck (MRK) stake by 1.8% in Q3 2025, selling an estimated $122K and leaving 81,536 shares worth $6.84M. The position accounts for 0.28% of the portfolio, ranked #49.
Laird Norton Wetherby Wealth Management first reported a position in MRK in Q2 2013 and has held it in 49 quarters since. The position peaked at $15.8M in Q1 2024. 3,309 funds tracked by Wall St. Rank hold MRK as of Q3 2025.
- Laird Norton Wetherby Wealth Management held 81,536 shares of Merck worth $6.84M as of Q3 2025.
- Laird Norton Wetherby Wealth Management sold 1,476 Merck shares in Q3 2025, an estimated $122K.
- Merck made up 0.28% of Laird Norton Wetherby Wealth Management's portfolio in Q3 2025, its #49 holding.
- Laird Norton Wetherby Wealth Management first reported a position in Merck in Q2 2013 and has held it in 49 quarters since.
- Laird Norton Wetherby Wealth Management's Merck position peaked at $15.8M in Q1 2024.
- 3,309 funds tracked by Wall St. Rank held Merck as of Q3 2025.
Based on Laird Norton Wetherby Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.